Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Morphic Holding Inc (MORF)

Morphic Holding Inc (MORF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Morphic Holding Inc 35 Gatehouse Drive A2 Waltham MA 02451 USA

P: 781-996-0955

Description:

Morphic Holding Inc. is a biopharmaceutical company. It focuses on the discovery and development of oral small-molecule integrin therapeutics for autoimmune, cardiovascular and metabolic diseases, as well as fibrosis and cancer. Morphic Holding Inc. is based in Waltham, Massachusetts.

Key Statistics

Overview:

Market Capitalization, $K 1,060,979
Enterprise Value, $K 652,849
Shares Outstanding, K 38,553
Annual Sales, $ 19,790 K
Annual Net Income, $ -95,540 K
Last Quarter Sales, $ 2,060 K
Last Quarter Net Income, $ -30,020 K
60-Month Beta 1.26
% of Insider Shareholders 26.30%
% of Institutional Shareholders 81.64%
Float, K 28,414
% Float 73.70%
Short Volume Ratio 0.38

Growth:

1-Year Return -38.55%
3-Year Return 67.70%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.78 on 11/02/22
Next Earnings Date 11/03/22
Earnings Per Share ttm -1.52
EPS Growth vs. Prev Qtr -214.71%
EPS Growth vs. Prev Year -13.04%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

MORF Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -15.98%
Return-on-Assets % -13.79%
Profit Margin % -482.77
Net Margin % N/A
Debt/Equity 0.00
Price/Sales 51.79
Price/Cash Flow N/A
Price/Book 2.80
Book Value/Share 9.49
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar